David is an expert in immunology and bioengineering with experience in developing translational technologies. He has published in top scientific journals, including Nature Biotechnology and Nature Communications. He obtained his PhD from Harvard University, where he worked on developing cutting-edge cancer therapies. These technologies are currently licensed to a clinical-stage biopharmaceutical company. In 2021, he co-founded Revela with Dr. Evan Zhao and Avinash Boppana to bridge the gap between beauty and biotechnology through the discovery of new molecules. Recently, Revela was acquired by ODDITY, the leading consumer technology platform disrupting the global beauty and wellness market. The pairing will unleash the power of biotechnology and AI drug discovery in an outdated industry, providing science-backed, clinically-tested, and highly efficacious solutions to tackle the most pressing challenges faced by millions each day.